-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says
Kiniksa Pharmaceuticals (NASDAQ:KNSA – Free Report) had its price objective raised by Jefferies Financial Group from $40.00 to $45.00 in a report published on Tuesday morning,Benzinga reports. Jefferies Financial Group currently has a buy rating on the stock. A number of other research firms also recently commented on KNSA. Citigroup began coverage on Kiniksa Pharmaceuticals […]
Kiniksa Pharmaceuticals (NASDAQ:KNSA – Free Report) had its price objective raised by Jefferies Financial Group from $40.00 to $45.00 in a report published on Tuesday morning,Benzinga reports. Jefferies Financial Group currently has a buy rating on the stock. A number of other research firms also recently commented on KNSA. Citigroup began coverage on Kiniksa Pharmaceuticals […]
